Basic Information
| LncRNA/CircRNA Name | ARAP1-AS1 |
| Synonyms | NA |
| Region | GRCh38_11:72685075-72693808 |
| Ensemble | ENSG00000256007 |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | gastric cancer |
| ICD-0-3 | C16 |
| Methods | RT-PCR |
| Sample | GC tissues |
| Expression Pattern | up-regulated |
| Function Description | higher levels of ARAP1-AS1 had shorter overall survival (p=0.0020) and disease-free survival than those with lower levels of ARAP1-AS1. ARAP1-AS1 upregulation as an independent unfavorable prognostic factor in GC patients. |
| Pubmed ID | 32141550 |
| Year | 2020 |
| Title | Increased long non-coding RNA ARAP1-AS1 expression and its prognostic significance in human gastric cancer: a preliminary study |
External Links
| Links for ARAP1-AS1 | GenBank HGNC NONCODE |
| Links for gastric cancer | OMIM COSMIC |